Vlasov, Hanna http://orcid.org/0000-0002-8770-1963
Juvonen, Tatu
Hiippala, Seppo
Suojaranta, Raili
Peltonen, Markku
Schramko, Alexey
Arvonen, Kaapo
Salminen, Ulla-Stina
Kleine Budde, Ilona
Eränen, Tiina
Mazanikov, Maxim
Meinberg, Mihkel
Vähäsilta, Tommi
Wilkman, Erika
Pettilä, Ville
Pesonen, Eero
Funding for this research was provided by:
Helsingin ja Uudenmaan Sairaanhoitopiiri
Sanquin Plasma Products BV
Article History
Received: 27 August 2019
Accepted: 11 February 2020
First Online: 28 February 2020
Ethics approval and consent to participate
: The operative ethics committee of Helsinki University Hospital has approved the study protocol. Any modifications to the protocol will be immediately communicated to all responsible authorities.Eligible patients who undergo cardiac surgery at Meilahti Hospital (Helsinki University Hospital, Helsinki, Finland) will be recruited to the study. After obtaining informed consent, elective patients will be recruited during the perioperative screening visit for anesthesia. The patients scheduled for surgery during the index admission will be recruited as soon as the decision to perform surgery has been made and informed consent has been obtained.
: Not applicable.
: The trial is financially supported by Sanquin Plasma Products B.V. (SPP), the Netherlands, and SPP will conduct pharmacovigilance activities and reporting to the competent authorities. Employees of SPP will co-author the scientific article of the trial that will be published in a medical journal.